Editorial
 A DANGEROUS FDI POLICY   
 Wednesday, June 29, 2016 
 The Centre‚Äôs decision to allow 74 per cent foreign direct investments in brownfield pharmaceutical projects in automatic route will have serious implications in this critical sector and to the people of the country. 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]Cepheid gets clearance from US FDA for expanded claims for Xpert Carba-R test for 'superbugs'
11:00  [IST]Valeant Pharma, AstraZeneca agree to terminate licence to develop and commercialise brodalumab in Europe
10:00  [IST]GSK begins phase I clinical trial with investigational inducibile T-cell costimulator agonist antibody
09:00  [IST]Merck, Premier collaborate to co-develop solutions to help improve population health
more news >>
TOP NEWS
08:00  [IST]India needs a robust accreditation system for modern dentistry to flourish: Experts
08:00  [IST]WHO issues guidelines on validation on analytical method validation; expects industry to comment by month end
08:00  [IST]Kerala govt soon to initiate steps for establishing pharma park in the state
08:00  [IST]AMMOI urges PM to advise UPSC to consider Ayurveda as a subject in civil services exams
08:00  [IST]MSBB detects 9 cases of ABS non- compliance in state
08:00  [IST]IPC releases errata-010 containing amendments related to veterinary monographs
more news >>
YESTERDAY'S NEWS
17:30  [IST]Best Healthcare Brands 2016 felicitates best hospital brands in the industry
16:20  [IST]STEMI-India to hold two-day workshop on management of heart attack on July 2&3 with practical & theoretical guidance
16:10  [IST]Gene Box to offer healthcare solutions based on genetic analytics
15:25  [IST]Hilleman Lab scientist chosen for prestigious DBT Cambridge Lectureship
15:20  [IST]Medikoe teams up with Manipal to launch In-App SOS feature for emergency medical services
15:15  [IST]FIGO adopts a three pronged strategy to counter gestational diabetes
more news >>
INTERVIEW  
Need for responsible waste management by pharma industry to tackle antibiotic resistance
Anurag Roy, Business Unit Director, Asia Pacific, Middle East and Africa, DSM Sinochem Pharmaceuticals Pvt Ltd
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |